Results 81 to 90 of about 754 (147)

Interview with Luigi Ferrajoli: Considerations on Constitutionalism

, 2014
En la presente entrevista, el autor explica la positivización del constitucionalismo y su relación con el concepto de moral y el rol de las democracias contemporáneas. Asimismo, discute la problemática de la libertad de información en relación a los derechos de propiedad, a la iniciativa económica y a la libertad de expresión.
Dyer Cruzado, Edward, Feijóo, Raúl, Gamero, Ximena del Rosario   +2 more
openaire   +1 more source

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome. [PDF]

Cancer
DiNardo CD, Croden J, Abdel-Salam HM, Kadia T, Molica M, Bazinet A, Bose P, Maiti A, Haddad F, Burger J, Kantarjian H, Wierda W, Jain N, Ferrajoli A.   +13 more
europepmc   +1 more source

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. [PDF]

Ann Oncol, 2023
Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade JL, Lazar AJ, Mason R, Millward M, Sandhu S, Khoo C, Warburton L, Guerra V, Haydon A, Dearden H, Menzies AM, Carlino MS, Smith JL, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh SA, Markovic SN, Ding W, Call TG, Hampel PJ, Long GV, Wargo JA, Ferrajoli A.   +32 more
europepmc   +1 more source

Psychological Profiles in Ulcerative Colitis and Crohn's Disease: Distinct Emotional and Behavioral Patterns. [PDF]

Biomedicines
D'Onofrio AM, Maggio E, Milo V, Ferrajoli GF, Ferrarese D, Chieffo DPR, Luciani M, Gasbarrini A, Sani G, Scaldaferri F, Calia R, Camardese G.   +11 more
europepmc   +1 more source

Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial. [PDF]

J Clin Oncol, 2023
Hillmen P, Eichhorst B, Brown JR, Lamanna N, O'Brien SM, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Österborg A, Yimer HA, Salmi T, Ji M, Yecies J, Idoine A, Wu K, Huang J, Jurczak W.   +27 more
europepmc   +1 more source

Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression. [PDF]

Blood Cancer J
Tantawy SI, Aslan B, Manyam G, Iles LR, Timofeeva N, Singh N, Jain N, Ferrajoli A, Thompson PA, Patel KP, Desikan SP, Wierda WG, Gandhi V.   +12 more
europepmc   +1 more source

A phase two study of high dose blinatumomab in Richter's syndrome. [PDF]

Leukemia, 2022
Thompson PA, Jiang X, Banerjee P, Basar R, Garg N, Chen K, Kaplan M, Nandivada V, Cortes AKN, Ferrajoli A, Keating MJ, Peterson CB, Andreeff M, Rezvani K, Wierda WG.   +14 more
europepmc   +1 more source

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports. [PDF]

Blood Vessel Thromb Hemost
Subramanian N, Garcia Pleitez H, Nguyen D, Milton DR, Kebriaei P, Shpall E, Cheng L, Lu J, Jin S, Wu CC, Sheth RA, Ferrajoli A, Toale KM, Kroll MH, Rojas-Hernandez CM.   +14 more
europepmc   +1 more source

Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. [PDF]

Am J Hematol, 2022
Jabbour E, Sasaki K, Haddad FG, Issa GC, Skinner J, Dellasala S, Yilmaz M, Ferrajoli A, Bose P, Thompson P, Alvarado Y, Jain N, Garcia-Manero G, Takahashi K, Borthakur G, Pemmaraju N, Pierce S, Kantarjian H.   +17 more
europepmc   +1 more source

Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study. [PDF]

Microorganisms
Scaldaferri F, D'Onofrio AM, Chiera E, Gomez-Nguyen A, Ferrajoli GF, Di Vincenzo F, Petito V, Laterza L, Pugliese D, Napolitano D, Schiavoni E, Spagnolo G, Ferrarese D, Putignani L, Lopetuso LR, Cammarota G, Cominelli F, Gasbarrini A, Sani G, Camardese G.   +19 more
europepmc   +1 more source